Reserve your spot in The SOLSTICE Study
We are excited to announce our current research study, the SOLSTICE Study! If you'd like to reserve a spot, click the link below to book your initial appointment. You can find study requirements and details below.
The SOLSTICE Study will last 3 months. Participants will be asked to use SOLIUS 3 times per month. We are evaluating the ability of SOLIUS to replace oral vitamin D supplements therefore, all subjects will be required to stop taking vitamin D supplements for the duration of the study. Enrolled participants are expected to pay $150 by the end of the study to help offset costs. Waivers are available for participants in financial need. There will be two (2) finger-prick blood tests measuring biomarkers of vitamin D in the blood: an initial baseline test and again after three months. The initial appointment will last about 45 minutes, consisting of screening to determine eligibility for participation, paperwork, the baseline finger-prick blood test, account setup, and the first SOLIUS session. Remaining treatment appointments should take no longer than 10 minutes from start to finish, and you will have the flexibility to come in at any time during open hours of the study.
To reserve your spot in the trial, book an appointment by clicking the button above. Once you've booked, click the "Informed Consent" button to download the consent form. Please read thoroughly and feel free to consult with your physician. Additional copies will be available at your appointment. We request that you bring in any medication or nutritional supplements that you are currently taking. Let us know if you have any questions and feel free to contact us at anytime at [email protected]. We are very happy to provide you with more information.
SOLIUS is a self-care device that delivers a narrow bandwidth of light to stimulate the body's natural production of vitamin D.
SOLIUS is located at
100 Ravine Lane NE
Bainbridge Island, WA, 98110
SOLIUS is an investigational device and has not yet been cleared by the FDA.